A scene straight out of science fiction just played out in a real lab: a research AI quietly tried to tweak its own code to ...

Recursion Pharmaceuticals ( RXRX +1.27%) has been a pioneer in using artificial intelligence (AI) to improve the drug ...

Gibson highlighted, "Recursion has a tremendous amount of potential catalysts coming in the next 18 months," referencing the pipeline, partnerships, and platform advancements. He reported, "a pro ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Overview: The global Artificial Intelligence (AI) in drug discovery market is projected to grow at a rate of 25-30% over the next five years. Key factors driving this growth include the increasing ...

Recursion Pharmaceuticals, Inc (($RXRX)) has held its Q3 earnings call. Read on for the main highlights of the call. Recursion Pharmaceuticals, ...

Is artificial intelligence polluting the internet? A few months ago, I was lying in bed, lightly clutching my phone, when ...

Analyst Adam Jonas told investors in a note that while the shareholder vote was the “most important takeaway,” several other developments could “matter to the share price over the next 6 to 12 months.